AI meets Epigenetics

Beauty ForumHIGHTECH-BEAUTY – March 2025

With rapid technological advances, we are entering a bold new world where artificial intelligence (AI) and epigenetics unite to redefine skincare.

ai epigenetic beauty forum

Intelligence in skincare

Integrating AI enables us to develop innovative solutions that are faster and more precise than ever. AI platforms can analyze billions of physical and hypothetical molecular combinations to predict which will most effectively interact with specific genes or pathways responsible for collagen synthesis, cell turnover, and combating inflammation. This revolutionary technique accelerates the development of new skincare ingredients, saving time and cost compared to traditional research methods, making the industry more efficient, accessible, and scalable.

ai epigenetic beauty forum

Did you know? The AI market in the beauty industry is estimated to reach USD 13.5 billion by 2030, with 72 % of consumers ready to adopt personalized skincare solutions.

Another key area where AI plays a critical role is in predicting skin sensitivity. Through machine learning and chemical structure analysis, AI can anticipate which ingredients might cause irritation or allergic reactions. This has profound ethical and practical implications, potentially reducing the need for animal testing by virtually screening out problematic substances before clinical trials.

Furthermore, AI-driven personalization in skincare has received a major boost. Using image recognition and computer vision, the technology can identify various skin conditions, and it is foreseeable that it will soon detect early signs of skin issues like hyperpigmentation. This could lead to more individualized and precise product recommendations tailored to skin needs.

Skin reprogramming: epigenetic actives

Alongside AI-driven skincare, epigenetics comes into play: epigenetic actives form a new generation of skincare ingredients that specifically target genes related to skin aging, collagen production, and cellular regeneration. These ingredients, such as peptides and polyphenols, can influence gene expression to promote a younger, healthier epigenetic profile. They essentially “reprogram” skin at a cellular level to optimize its natural functions.

The advantage of these epigenetic approaches is their ability to rejuvenate and regenerate skin in the long term by targeting the genetic mechanisms that drive aging. This technology could elevate skincare to a whole new level by addressing not just surface symptoms but core biological processes that significantly impact skin health.

Target acquired: delivery technologies

Finding the right actives is only part of the challenge — the crucial step is ensuring they are effectively delivered into the skin. Advanced encapsulation technologies like liposomes, niosomes, and nanoparticles are key to transporting actives optimally. These technologies offer several benefits:

  • They protect sensitive molecules from harmful environmental factors like light, oxygen, and unfavorable pH.

  • They enhance skin barrier penetration, allowing actives to reach deeper layers.

  • They ensure controlled release, reducing irritation and boosting product efficacy over time.

Wrinkle terminators: LED, microcurrent, and ultrasound

Beyond ingredient choice, modern devices offer complementary opportunities to optimize skincare outcomes:

  • LED therapy uses light-emitting diodes at specific wavelengths to stimulate collagen production, cell repair, or fight acne-causing bacteria.

  • Microcurrents applied to the face stimulate facial muscles, improving elasticity, firming, and reducing sagging.

  • High-Intensity Focused Ultrasound (HIFU) has the potential to enhance product penetration.

Future developments may bring standardized devices specifically engineered to support transdermal absorption.

Conclusion

With the latest advances in epigenetics, AI, and delivery technologies, we can shape the future of our skin. In this future, beauty isn’t just about looking younger — it’s about achieving deep, personalized, technology-driven transformation that helps us both look and feel healthier.

Dr. Ivan de Weber

Dr. Ivan de Weber

CSO The Age Tech

Dr. Ivan de Weber is a scientist and entrepreneur dedicated to longevity research.

He is the co-founder of Cortex Discovery, an AI-driven active ingredient development company.

He is also the co-founder of The Age Tech, creator of The Age Tech Serum, an epigenetic-based anti-aging serum that targets all visible signs of skin aging

Others articles

Client services

Contact us

The Age Tech SA
Rue Cité-Derrière 15
CH-1005 Lausanne
hello@theagetech.ch

Social media

Newsletter

Client services

Contact us

The Age Tech SA
Rue Cité-Derrière 15
CH-1005 Lausanne
hello@theagetech.ch

Social media

Newsletter

Client services

Contact us

Social media

Newsletter

Share This